Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
56.40
+1.30 (2.36%)
Aug 13, 2025, 9:58 AM - Market open

Akoya Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
7,0333,7753,2832,78610,16812,884
Upgrade
Market Cap Growth
82.43%14.96%17.84%-72.60%-21.09%75.59%
Upgrade
Enterprise Value
7,8424,1873,4873,0459,85011,923
Upgrade
Last Close Price
55.1030.5527.0527.20100.02128.88
Upgrade
PS Ratio
8.225.115.826.2027.2144.94
Upgrade
PB Ratio
--27.0320.6946.3015.769.51
Upgrade
P/TBV Ratio
--22.4361.6916.2010.07
Upgrade
EV/Sales Ratio
9.465.676.186.7726.3641.58
Upgrade
Debt / Equity Ratio
-4.37-9.578.5322.752.130.63
Upgrade
Asset Turnover
0.560.450.330.240.170.18
Upgrade
Inventory Turnover
4.084.364.003.804.604.88
Upgrade
Quick Ratio
2.744.216.115.745.2927.66
Upgrade
Current Ratio
3.714.686.546.175.7228.27
Upgrade
Return on Equity (ROE)
--4584.47%-438.12%-185.65%-38.46%-22.35%
Upgrade
Return on Assets (ROA)
-19.57%-16.95%-17.71%-17.84%-11.48%-9.85%
Upgrade
Return on Capital (ROIC)
-24.30%-20.47%-20.45%-19.73%-12.15%-10.29%
Upgrade
Earnings Yield
-5.89%-11.56%-14.60%-23.49%-3.99%-1.97%
Upgrade
FCF Yield
-3.86%-7.28%-10.52%-13.89%-2.79%-1.09%
Upgrade
Buyback Yield / Dilution
-2.95%-9.61%-9.60%-0.85%-3.91%-7.62%
Upgrade
Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q